デフォルト表紙
市場調査レポート
商品コード
997998

世界の淋病治療薬市場:COVID-19の影響分析、タイプ別、サンプリングレート別、用途別、地域別-規模、シェア、予測(2021~2027年)

Global Gonorrhea Therapeutics Market with COVID-19 Impact Analysis, By Type, By Sampling Rate, By Application and By Region - Size, Share, & Forecast from 2021-2027

出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 290 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.41円
世界の淋病治療薬市場:COVID-19の影響分析、タイプ別、サンプリングレート別、用途別、地域別-規模、シェア、予測(2021~2027年)
出版日: 2021年03月01日
発行: AnalystView Market Insights
ページ情報: 英文 290 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の淋病治療薬の市場規模は2019年までに9億8,020万米ドルとなりました。同市場は、2021年から2027年にかけて4.1%のCAGRで拡大すると予測されています。

淋病治療薬は、男性と女性の両方に感染する性感染症によって引き起こされる感染症です。淋病の有病率の上昇、全国的なスクリーニングプログラムの実施、国民の意識の高まりなどの主な要因は、淋病治療薬市場の成長を推進しています。疾病管理予防センター(CDC)によると、毎年約70万人の新しい淋病の症例が検出されています。 2019年、国立アレルギー感染症研究所(NIAID)は、梅毒、淋病、クラミジアの原因となる細菌調査共同の学際的な研究を支援するために、5年間で4,160万米ドルを供与しました。したがって、性感染症の有病率の上昇は、全国的なキャンペーンを通じて患者の意識を高め、政府のイニシアチブの強化が市場の成長を促進すると予想されます。ただし、厳しい規制シナリオとSTDクリニックを訪れる患者に関わる社会的不名誉が、予測期間中の米国市場の成長を抑制すると予想されます。

当レポートでは、世界の淋病治療薬市場について調査し、市場の概要とともに、淋菌感染症別、投与ルート別、治療別、流通チャネル別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 淋病治療薬市場概要

第2章 エグゼクティブサマリー

  • 市場内訳
    • 淋菌感染別市場内訳
    • 投与ルート別の市場内訳
    • 治療別市場内訳
    • 流通チャネル別の市場内訳
    • 用途別の市場内訳
    • 地域別の市場内訳
  • 競合考察

第3章 淋病治療薬の主要な市場動向

  • 市場の推進力
    • 市場成長要因の影響分析
  • 市場の抑制要因
    • 市場の抑制要因の影響分析
  • 市場機会
  • 市場の将来動向

第4章 淋病治療薬業界の研究

  • ポーターのファイブフォース分析
  • マーケティング戦略分析
  • 成長見通しマッピング
  • 規制の枠組み分析

第5章 淋病治療薬市場:COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析
    • トップパフォーマンスセグメント
    • 限界成長セグメント
    • トップルーザーセグメント
    • 限界損失セグメント

第6章 淋病治療薬市場情勢の展望

  • 市場シェア分析、2019年
  • キーイノベーター分析
  • 主要メーカー別の内訳データ
    • 老舗プレーヤーの分析
    • 新興プレーヤーの分析

第7章 淋菌治療薬市場-淋菌感染症別

  • 概要
  • 合併症のない淋菌感染症
  • 淋菌性関節炎
  • 淋菌性髄膜炎および心内膜炎

第8章 淋病治療薬市場-投与ルート別

  • 概要
  • 経口
  • 注射

第9章 淋病治療薬市場-治療別

  • 概要
  • 単剤療法
  • デュアルセラピー

第10章 淋病治療薬市場-流通チャネル別

  • 概要
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • その他

第11章 淋病治療薬市場-用途別

  • 概要
  • クリニック
  • 病院
  • その他

第12章 淋病治療薬市場-地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋(APAC)
  • ラテンアメリカ
  • 中東とアフリカ

第13章 ベンダー分析

  • 競争力ダッシュボード
  • 企業プロファイル
    • Danaher
    • Abbott
    • Becton Dickinson and Company
    • GlaxoSmithKline plc.
    • Merck & Co., Inc.
    • Pfizer Inc
    • AstraZeneca
    • Hologic, Inc.
    • LUPIN
    • Sun Pharmaceutical Industries Ltd,
    • Aurobindo Pharma
    • Hikma Pharmaceuticals PLC,
    • Mylan NV
    • Mayne Pharma Group Limited
    • WOCKHARDT
    • Nostrum Laboratories Inc,
    • Genocea Biosciences, Inc

第14章 アナリストの全方位的展望

第15章 付録

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Gonorrhea Therapeutics market: Gonococcal Infections Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Gonococcal Infections
  • TABLE Global Gonorrhea Therapeuticsmarket, by Gonococcal Infections2016-2027 (USD Million)
  • TABLE Gonorrhea Therapeutics market: Route of Administration Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Gonorrhea Therapeuticsmarket, by Route of Administration s2016-2027 (USD Million)
  • TABLE Global Gonorrhea Therapeutics market, by Treatment2016-2027 (USD Million)
  • TABLE Gonorrhea Therapeutics market: Treatment Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Treatment
  • TABLE Global Gonorrhea Therapeutics market, by Distribution Channel 2016-2027 (USD Million)
  • TABLE Gonorrhea Therapeutics market: Distribution Channel Snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Gonorrhea Therapeutics market, by Application 2016-2027 (USD Million)
  • TABLE Gonorrhea Therapeutics market: Application Snapshot (2019)
  • TABLE Gonorrhea Therapeutics market: Regional snapshot (2019)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Gonorrhea Therapeuticsmarket, by Region 2016-2027 (USD Million)
  • TABLE North America Gonorrhea Therapeutics market, by Country, 2016-2027 (USD Million)
  • TABLE North America Gonorrhea Therapeutics market, by Gonococcal Infections, 2016-2027 (USD Million)
  • TABLE North America Gonorrhea Therapeutics market, by Treatment, 2016-2027 (USD Million)
  • TABLE North America Gonorrhea Therapeutics market, by Distribution Channel, 2016-2027 (USD Million)
  • TABLE North America Gonorrhea Therapeutics market, by Application, 2016-2027 (USD Million)
  • TABLE Europe Gonorrhea Therapeutics market, by Country, 2016-2027 (USD Million)
  • TABLE Europe Gonorrhea Therapeutics market, by Gonococcal Infections, 2016-2027 (USD Million)
  • TABLE Europe Gonorrhea Therapeutics market, by Route of Administration, 2016-2027 (USD Million)
  • TABLE Europe Gonorrhea Therapeutics market, by Treatment, 2016-2027 (USD Million)
  • TABLE Europe Gonorrhea Therapeutics market, by Distribution Channel, 2016-2027 (USD Million)
  • TABLE Europe Gonorrhea Therapeutics market, by Application, 2016-2027 (USD Million)
  • TABLE Asia Pacific Gonorrhea Therapeutics market, by Country, 2016-2027 (USD Million)
  • TABLE Asia Pacific Gonorrhea Therapeutics market, by Gonococcal Infections, 2016-2027 (USD Million)
  • TABLE Asia Pacific Gonorrhea Therapeutics market, by Route of Administration, 2016-2027 (USD Million)
  • TABLE Asia Pacific Gonorrhea Therapeutics market, by Treatment, 2016-2027 (USD Million)
  • TABLE Asia Pacific Gonorrhea Therapeutics market, by Distribution Channel, 2016-2027 (USD Million)
  • TABLE Asia Pacific Gonorrhea Therapeutics market, by Application, 2016-2027 (USD Million)
  • TABLE Latin America Gonorrhea Therapeutics market, by Country, 2016-2027 (USD Million)
  • TABLE Latin America Gonorrhea Therapeutics market, by Gonococcal Infection, 2016-2027 (USD Million)
  • TABLE Latin America Gonorrhea Therapeutics market, by Route of Administration, 2016-2027 (USD Million)
  • TABLE Latin America Gonorrhea Therapeutics market, by Treatment, 2016-2027 (USD Million)
  • TABLE Latin America Gonorrhea Therapeutics market, by Distribution Channel, 2016-2027 (USD Million)
  • TABLE Latin America Gonorrhea Therapeutics market, by Applicationel, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Gonorrhea Therapeutics market, by Country, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Gonorrhea Therapeutics market, by Gonococcal Infection, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Gonorrhea Therapeutics market, by Route of Administration, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Gonorrhea Therapeutics market, by Treatment, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Gonorrhea Therapeutics market, by Distribution Channel, 2016-2027 (USD Million)
  • TABLE Middle East and Africa Gonorrhea Therapeutics market, by Application, 2016-2027 (USD Million)

List of Figures

  • FIGURE Gonorrhea Therapeutics market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2019
  • FIGURE Gonococcal Infection segment market share analysis, 2020 & 2027
  • FIGURE Gonococcal Infection segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Route of Administration segment market share analysis, 2020 & 2027
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Treatment segment market share analysis, 2020 & 2027
  • FIGURE Treatment segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Distribution Channel segment market share analysis, 2020 & 2027
  • FIGURE Distribution Channel segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Regional segment market share analysis, 2020 & 2027
  • FIGURE Regional segment market size forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE North America Gonorrhea Therapeutics market share and leading players, 2019
  • FIGURE Europe Gonorrhea Therapeutics market share and leading players, 2019
  • FIGURE Asia Pacific Gonorrhea Therapeuticsmarket share and leading players, 2019
  • FIGURE Latin America Gonorrhea Therapeuticsmarket share and leading players, 2019
  • FIGURE Middle East and Africa Gonorrhea Therapeuticsmarket share and leading players, 2019
  • FIGURE North America market share analysis by country, 2019
  • FIGURE U.S. Gonorrhea Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Canada Gonorrhea Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Europe Gonorrhea Therapeutics market share analysis by country, 2019
  • FIGURE Germany Gonorrhea Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Spain Gonorrhea Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Italy Gonorrhea Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE UK Gonorrhea Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE France Gonorrhea Therapeuticsmarket size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of the Europe Gonorrhea Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Asia Pacific Gonorrhea Therapeutics market share analysis by country, 2019
  • FIGURE India Gonorrhea Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE China Gonorrhea Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Japan Gonorrhea Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE South Korea Gonorrhea Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Singapore Gonorrhea Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of APAC Gonorrhea Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America Gonorrhea Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Latin America Gonorrhea Therapeutics market share analysis by country, 2019
  • FIGURE Brazil Gonorrhea Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Mexico Gonorrhea Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Argentina Gonorrhea Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Rest of LATAM Gonorrhea Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa Gonorrhea Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE Middle East and Africa Gonorrhea Therapeutics market share analysis by country, 2019
  • FIGURE Saudi Arabia Gonorrhea Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
  • FIGURE United Arab Emirates Gonorrhea Therapeutics market size, forecast and trend analysis, 2016 to 2027 (USD Million)
目次

REPORT HIGHLIGHT

The global Gonorrhea Therapeutics market size was valued at USD 980.2 million by 2019, growing with 4.1% CAGR during the forecast period, 2021-2027.

Gonorrhea Therapeutics is an infection caused by a sexually transmitted bacterium that infects both males and females. The primary factors such as the rising prevalence of gonorrhea, implementation of national screening programs, and growing public awareness are propelling the growth of the gonorrhea therapeutics market. According to the Centers for Disease Control and Prevention (CDC), around 700,000 new cases of gonorrhea are detected each year. In 2019, the National Institute of Allergy and Infectious Diseases (NIAID) has granted USD 41.6 million over five years to support collaborative, multidisciplinary research on the bacteria that cause syphilis, gonorrhea, and chlamydia. Thus, the growing prevalence of STDs increases patient awareness through national campaigns, and growing government initiatives are anticipated to drive market growth. However, stringent regulatory scenarios and social stigma associated with patients visiting STD clinics are expected to restrain the growth of the United States market in the forecast period.

Segmentation Analysis:

The gonorrhea therapeutics market is divided based on the treatment, gonococcal infection, application, distribution channel, route of administration, and region.

By treatment, the market has been segmented into monotherapy and dual therapy. Gonorrhea, caused by Neisseria gonorrhoeae, is the second most common bacterial STI and results in substantial morbidity. The dual therapy segment is estimated to dominate the United States market, and this trend is expected to continue over the forecast period. Dual therapy with ceftriaxone and azithromycin is recommended as the first-line regimen for the treatment of gonorrhea.

On the basis of gonococcal infection, the market is categorized as uncomplicated gonococcal infection, gonococcal arthritis & gonococcal meningitis, and endocarditis. Amidst this category, the uncomplicated gonococcal infection has a major share in the gonorrhea therapeutics market. Uncomplicated infections are much more common, encompassing any urogenital, anogenital, or pharyngeal infection caused by N gonorrhea that does not result in bacteremia.

By application, the market has been segmented into clinics and hospitals. Amidst this category, hospitals have a major share in the gonorrhea therapeutics market as hospitals remain preferred care centers for patients diagnosed with gonorrhea.

Based on the distribution channel, the United States gonorrhea therapeutics market has been divided into hospital pharmacies, retail pharmacies, online pharmacies, and others. The hospital pharmacy segment is estimated to dominate the gonorrhea therapeutics market by the end of 2031. The sales of gonorrhea therapeutics are projected to witness significant uptake from hospital pharmacies, as hospitals remain preferred care centers for patients diagnosed with gonorrhea.

Competitive Landscape:

Key players operating in the global gonorrhea therapeutics market include Merck & Co., Inc., GlaxoSmithKline plc., Pfizer Inc, AstraZeneca, Danaher., Hologic, Inc., Abbott, Becton Dickinson and Company, F. Hoffmann-La Roche Ltd. These players are adopting strategies such as new product development, partnerships, and acquisitions to remain competitive in the United States gonorrhea therapeutics market.

Also, several leading organizations and companies have started to develop new medicines and treatments for the treatment of the global gonorrhea therapeutics market. For instance, in Sept 2019, the Global Antibiotic Research and Development Partnership (GARDP), a not-for-profit organization has planned to develop drug-resistant infections treatments for gonorrhea by partnering with Entasis Therapeutics a clinical-stage biopharmaceutical company. The company focused on the discovery and development of novel antibacterial products and recently started a global phase 3 pivotal trial with Zoliflodacin drug for gonorrhea. Zoliflodacin is a novel, first-in-class oral antibiotic treatment drug for uncomplicated gonorrhea.

Key features of the study:

This proposed research study on Gonorrhea Therapeutics market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2020-2027), considering 2019 as the base year

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Gonorrhea Therapeutics market

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Gonorrhea Therapeutics market

Impact of COVID-19 on Gonorrhea Therapeutics market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Gonorrhea Therapeutics market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the Gonorrhea Therapeutics market, we have also included competitive landscape and key innovator analysis for the Gonorrhea Therapeutics market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and TYPE attractiveness.

The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Gonorrhea Therapeutics market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new TYPE launch, research & development, regional expansion of major participants involved in the electric tooth brush market on global as well as regional level.

The global Gonorrhea Therapeutics market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GONORRHEA THERAPEUTICS MARKET KEY PLAYERS

Danaher

Abbott

Becton Dickinson and Company

GlaxoSmithKline plc.

Merck & Co., Inc.

Pfizer Inc

AstraZeneca

Hologic, Inc.

LUPIN

Sun Pharmaceutical Industries Ltd,

Aurobindo Pharma

Hikma Pharmaceuticals PLC,

Mylan N.V.

Mayne Pharma Group Limited

WOCKHARDT

Nostrum Laboratories Inc,

Genocea Biosciences, Inc.

GLOBAL GONORRHEA THERAPEUTICS MARKET, BY GONOCOCCAL INFECTION

Uncomplicated Gonococcal Infection

Gonococcal Arthritis

Gonococcal Meningitis and Endocarditis

GLOBAL GONORRHEA THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION

Oral

Injectable

GLOBAL GONORRHEA THERAPEUTICS MARKET, BY TREATMENT

Monotherapy

Dual Therapy

GLOBAL GONORRHEA THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Others

GLOBAL GONORRHEA THERAPEUTICS MARKET, BY APPLICATION

Clinics

Hospitals

Others

GLOBAL GONORRHEA THERAPEUTICS MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Singapore

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

The Middle East and Africa

Saudi Arabia

United Arab Emirates

Rest of MEA

TABLE OF CONTENT

1. Gonorrhea Therapeutics Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Gonococcal Infection
    • 2.1.2. Market Snippet by Route of Administration
    • 2.1.3. Market Snippet by Treatment
    • 2.1.4. Market Snippet by Distribution Channel
    • 2.1.5. Market Snippet by Application
    • 2.1.6. Market Snippet by Region
  • 2.2. Competitive Insights

3. Gonorrhea Therapeutics Key Market Trends

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. Gonorrhea Therapeutics Industry Study

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Gonorrhea Therapeutics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Gonorrhea Therapeutics Market Landscape

  • 6.1. Market Share Analysis, 2019
  • 6.2. Key Innovators Analysis
  • 6.3. Breakdown Data, by Key Manufacturer
    • 6.3.1. Established Players' Analysis
    • 6.3.2. Emerging Players' Analysis

7. Gonorrhea Therapeutics Market - By Gonococcal Infection

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Gonococcal Infection, 2020 & 2027 (%)
  • 7.2. Uncomplicated Gonococcal Infection
  • 7.3. Gonococcal Arthritis
  • 7.4. Gonococcal Meningitis and Endocarditis

8. Gonorrhea Therapeutics Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment, 2020 & 2027 (%)
  • 8.2. Oral
  • 8.3. Injectable

9. Gonorrhea Therapeutics Market - By Treatment

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Treatment, 2020 & 2027 (%)
  • 9.2. Monotherapy
  • 9.3. Dual Therapy

10. Gonorrhea Therapeutics Market - By Distribution Channel

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Distribution Channel, 2020 & 2027 (%)
  • 10.2. Hospital Pharmacies
  • 10.3. Retail Pharmacies
  • 10.4. Online Pharmacies
  • 10.5. Others

11. Gonorrhea Therapeutics Market - By Application

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Application, 2020 & 2027 (%)
  • 11.2. Clinics
  • 11.3. Hospitals
  • 11.4. Others

12. Gonorrhea Therapeutics Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2020 & 2027 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Gonococcal Infection, 2016 - 2027 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Gonococcal Infection, 2016 - 2027 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
      • 12.2.9.8.
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 1.1.1.1. Canada Market Size and Forecast, By Gonococcal Infection, 2016 - 2027 (US$ Million)
      • 1.1.1.2. Canada Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
      • 1.1.1.3. Canada Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
      • 1.1.1.4. Canada Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
      • 1.1.1.5. Canada Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Gonococcal Infection, 2016 - 2027 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Gonococcal Infection, 2016 - 2027 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 12.3.10. Italy
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 12.3.10.3. Italy Market Size and Forecast, By Gonococcal Infection, 2016 - 2027 (US$ Million)
      • 12.3.10.4. Italy Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
      • 12.3.10.5. Italy Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
      • 12.3.10.6. Italy Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
      • 12.3.10.7. Italy Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 12.3.11. United Kingdom
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 12.3.11.3. United Kingdom Market Size and Forecast, By Gonococcal Infection, 2016 - 2027 (US$ Million)
      • 12.3.11.4. United Kingdom Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
      • 12.3.11.5. United Kingdom Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
      • 12.3.11.6. United Kingdom Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
      • 12.3.11.7. United Kingdom Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 12.3.12. France
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 12.3.12.3. France Market Size and Forecast, By Gonococcal Infection, 2016 - 2027 (US$ Million)
      • 12.3.12.4. France Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
      • 12.3.12.5. France Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
      • 12.3.12.6. France Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
      • 12.3.12.7. France Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 12.3.13. Rest of Europe
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 12.3.13.3. Rest of the Europe Market Size and Forecast, By Gonococcal Infection, 2016 - 2027 (US$ Million)
      • 12.3.13.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
      • 12.3.13.5. Rest of the Europe Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
      • 12.3.13.6. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
      • 12.3.13.7. Rest of the Europe Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Key Manufacturers in Asia Pacific
    • 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 12.4.4. Asia Pacific Market Size and Forecast, By Gonococcal Infection, 2016 - 2027 (US$ Million)
    • 12.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
    • 12.4.6. Asia Pacific Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
    • 12.4.7. Asia Pacific Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 12.4.8. Asia Pacific Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 12.4.9. India
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 12.4.9.3. India Market Size and Forecast, By Gonococcal Infection, 2016 - 2027 (US$ Million)
      • 12.4.9.4. India Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
      • 12.4.9.5. India Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
      • 12.4.9.6. India Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
      • 12.4.9.7. India Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 12.4.10. China
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 12.4.10.3. China Market Size and Forecast, By Gonococcal Infection, 2016 - 2027 (US$ Million)
      • 12.4.10.4. China Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
      • 12.4.10.5. China Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
      • 12.4.10.6. China Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
      • 12.4.10.7. China Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Gonococcal Infection, 2016 - 2027 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Gonococcal Infection, 2016 - 2027 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 12.4.13. Rest of APAC
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 12.4.13.3. Rest of APAC Market Size and Forecast, By Gonococcal Infection, 2016 - 2027 (US$ Million)
      • 12.4.13.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
      • 12.4.13.5. Rest of APAC Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
      • 12.4.13.6. Rest of APAC Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
      • 12.4.13.7. Rest of APAC Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
  • 12.5. Latin America
    • 12.5.1. Overview
    • 12.5.2. Key Manufacturers in Latin America
    • 12.5.3. Latin America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 12.5.4. Latin America Market Size and Forecast, By Gonococcal Infection, 2016 - 2027 (US$ Million)
    • 12.5.5. Latin America Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
    • 12.5.6. Latin America Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
    • 12.5.7. Latin America Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 12.5.8. Latin America Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Gonococcal Infection, 2016 - 2027 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Gonococcal Infection, 2016 - 2027 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Gonococcal Infection, 2016 - 2027 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 12.5.12. Rest of LATAM
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 12.5.12.3. Rest of LATAM Market Size and Forecast, By Gonococcal Infection, 2016 - 2027 (US$ Million)
      • 12.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
      • 12.5.12.5. Rest of LATAM Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
      • 12.5.12.6. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
      • 12.5.12.7. Rest of LATAM Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Gonococcal Infection, 2016 - 2027 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Gonococcal Infection, 2016 - 2027 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Gonococcal Infection, 2016 - 2027 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2016 - 2027 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)

13. Key Vendor Analysis

  • 13.1. Competitive Dashboard
  • 13.2. Company Profiles
    • 13.2.1. Danaher
    • 13.2.2. Abbott
    • 13.2.3. Becton Dickinson and Company
    • 13.2.4. GlaxoSmithKline plc.
    • 13.2.5. Merck & Co., Inc.
    • 13.2.6. Pfizer Inc
    • 13.2.7. AstraZeneca
    • 13.2.8. Hologic, Inc.
    • 13.2.9. LUPIN
    • 13.2.10. Sun Pharmaceutical Industries Ltd,
    • 13.2.11. Aurobindo Pharma
    • 13.2.12. Hikma Pharmaceuticals PLC,
    • 13.2.13. Mylan N.V.
    • 13.2.14. Mayne Pharma Group Limited
    • 13.2.15. WOCKHARDT
    • 13.2.16. Nostrum Laboratories Inc,
    • 13.2.17. Genocea Biosciences, Inc

14. 360 Degree AnalystView

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us